Company ProfilePremium

Sinomax Group Limited

Company Profile Analysis

Ticker: 1418.HK盛諾集團有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Sinomax Group Limited - Company showcase

Year Founded & Workforce

2000

4,028 Employees

Sinomax Group Limited logo

Sinomax Group Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Sinomax Group Limited Overview

Sinomax is a Hong Kong-headquartered, Cayman-incorporated, family-controlled manufacturer of polyurethane foam and visco-elastic ("memory foam") sleep products — pillows, mattress toppers and mattresses — with a vertically integrated chain running from foam pouring in China and Vietnam to finished-goods plants in the PRC, Vietnam and the United States. It earns roughly 71% of revenue from health and household products sold to North American and European retailers, private-label programmes and e-commerce, and through its own SINOMAX retail counters in Hong Kong and the PRC; the remaining ~29% comes from bulk polyurethane foam (Tung Ah brand) sold to Chinese furniture makers. Revenue reached a record HK$4.70bn in FY2025 and grew a further 36% in 1H2026 after the Group took control of Danish trading house M DK Holdings and bought the VIBE mattress brand outright. The equity story is a growth-versus-margin tension: scale and geographic diversification are rising quickly, but net margins are sub-2%, leverage is up, and the shares trade at roughly 0.2x book.


The company's own description

In its FY2025 annual results announcement, the Group describes itself simply: it "manufactures and sells health and household products", with the Company acting as an investment holding company. The 2026 interim results expand on this: the Group sells health and household products — "quality visco-elastic pillows, mattress toppers and mattresses" — to wholesalers and retailers and directly to customers through self-operated stand-alone retail shops, concession counters in department stores and online platforms; it also sells polyurethane foam to furniture manufacturers. Operating segments are defined geographically (China market; North American market; Europe and other overseas markets).

Historically (pre-2020 segmentation, as summarised by 10jqka from company disclosures) the Group reported three business lines: (i) Export sales — wholesale of products to overseas customers; (ii) Retail and corporate sales — sales under the SINOMAX brand via own network, third-party distributors, corporate customers and e-commerce; and (iii) Polyurethane foam sales — wholesale of foam under the Tung Ah (東亞) brand to PRC furniture manufacturers. Those three economic engines still exist inside today's geographic segments.

Independent characterisation

Sinomax is best understood as a mid-tier, vertically integrated foam-to-finished-goods OEM/ODM with three distinct revenue engines:

  1. North American OEM/private-label and e-commerce sleep products (FY2025: HK$1,773.6M, 37.8% of revenue). Sinomax USA manufactures mattresses (notably compressed "mattress-in-a-box"), toppers and pillows for large US bedding brands and retailers (historically including Serta Simmons Bedding, per the 2017 Annual Report) and for online channels, and since 2023 has marketed the VIBE brand (licensed from November 2022, owned outright from July 2025).

  2. China market (FY2025: HK$1,857.7M, 39.6%), which combines (a) a commodity-like B2B business selling polyurethane foam to Chinese furniture manufacturers — HK$1,369.9M of Group revenue in FY2025 is foam, almost all of it booked in this segment — and (b) a branded consumer business (SINOMAX retail shops, department-store concession counters and e-commerce in Hong Kong, Macau and the PRC).

  3. Europe and other overseas (FY2025: HK$1,065.4M, 22.7%), transformed in 2024–2025 by the M DK Holdings investment, which added a Danish sourcing/trading/design house selling sleep products, furniture and home accessories in Denmark, the EU and the US.

Revenue model

Revenue mix by product type (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Health and household products (HK$M)2,370.01,980.32,365.42,728.93,326.7
Polyurethane foam (HK$M)1,889.91,171.71,243.51,362.21,369.9
Total revenue (HK$M)4,259.93,152.03,608.94,091.14,696.7
Health & household share of revenue (%)55.662.865.566.770.8

Revenue is almost entirely product revenue recognised at a point in time (FY2025 notes: 100% of revenue from sale of goods). There is no material subscription, service or licensing income. Rental income (HK$9.6M in FY2025) and government subsidies (HK$7.9M) are reported as other income. The Group pays rather than receives royalties: accrued royalties were HK$18.8M at end-FY2025, consistent with licensed brands (e.g., the VIBE licence carried a minimum quarterly royalty of US$200,000 before the July 2025 buy-out).

Source: FY2022, FY2024, FY2025 annual results announcements, note 3.

Value-chain position and channels

Sinomax sits in the midstream: it buys chemical feedstocks (polyols, isocyanates/TDI-MDI and additives — inferred from the polyurethane process; specific supplier names are NPD), pours slabstock and visco-elastic foam in China and Vietnam, and converts foam into finished sleep products in China, Vietnam and the US. Channels are: (i) wholesale to brand owners and retailers (credit terms 7–90 days); (ii) department-store concession counters (department stores collect cash and remit net of commission on 30–120-day terms; concession commission HK$32.1M in FY2025); (iii) self-operated stand-alone shops; (iv) online platforms; and (v) foam sales to furniture manufacturers in the PRC.

Customer types and end-markets

Customers are (a) North American and European bedding brands, mass merchants and online retailers; (b) Chinese furniture manufacturers (foam); and (c) consumers in Hong Kong, Macau and the PRC. A single customer ("Customer A") contributed over 10% of revenue in FY2021 (HK$504.5M) and FY2022 (HK$329.7M); the identity is not disclosed, and no >10% customer was disclosed in the FY2024 or FY2025 announcements reviewed. End-markets are residential bedding (mattresses, toppers, pillows), upholstered furniture (via foam), and adjacent home-comfort products.

Strategy

Stated strategy — themes from the FY2025 Annual Results and 2026 Interim Results

Management's stated themes (paraphrased from the "Prospects" sections):

  1. Overseas expansion, especially Europe and the US — continue advancing ongoing projects in these regions and increase market share (FY2025 Prospects).

  2. Leverage the enlarged M DK platform — use MDKH's business platform and resources to deepen penetration in the US and Europe, strengthen sales and marketing, broaden the customer base and deepen existing relationships (1H2026 Prospects).

  3. Mattress-in-a-box growth — expects sales of mattress-in-a-box to keep growing and contribute more sales and profit (FY2022, FY2024, FY2025 Prospects).

  4. Streamline and cut costs — operational streamlining, resource allocation and synergies; cost-control in production and logistics (FY2024–1H2026).

  5. Multi-country production network as a tariff hedge — factories in the PRC, US and Vietnam allow flexible deployment of capacity amid trade wars, tariffs and anti-dumping duties (FY2024 Prospects; FY2025 profit warning).

  6. Brand ownership — move from licensee to owner (VIBE) to gain flexibility in positioning, marketing and expansion, including outside the licensed territories.

  7. Tone: the Board describes itself as "cautiously optimistic".

Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)

DateInitiativeDetailStatus
14 Oct 2024Europe entry via M DK Holdings (45%)EUR6.0M subscriptionCompleted; equity-accounted in FY2024 (share of profit HK$5.0M)
Oct–Dec 2024Dongguan capacitySupplemental premises lease Oct 2024; 2025 Dongguan Lease (10 Dec 2024)Completed
7 Jul 2025VIBE brand IP buy-outUS$4.6M; replaces licence with minimum royalty US$200k/quarterCompleted
4 Aug 2025M DK step-up to 55% (control)EUR5.0M; consolidated from 5 Aug 2025Completed; integration ongoing
Dec 2025VIBE retail expansionVIBE mattresses launched in Walmart stores; plan to build VIBE into a national lifestyle brandOngoing
19 Dec 20252026 Dongguan LeaseOne-year connected leaseCompleted
FY2025Cost programmeOffice expenses cut ≈HK$6.0M; "various cost control measures"Ongoing; no quantified target
FY2025ESG targets2030 targets: 5% reduction in emissions, energy and water intensity; ESG scope extended to US and Vietnam factoriesSet
1H2026Commercial build-outHeavy investment in sales, marketing, brand awareness and promotion in US and Europe; organisational capabilityOngoing; Q2 2026 expenses below Q1

Medium-term targets / guidance

Management has published no quantitative medium-term financial targets (revenue, margin, ROE or leverage) and no formal guidance in the documents reviewed. Guidance is qualitative only (see §22).

Products & Services

Sinomax does not publish a SKU-level catalogue in its regulatory filings, and pricing is not disclosed except where noted. The catalogue below combines filings, trade press and S&P Global-sourced brand lists. Brand ownership status (owned vs licensed) is stated only where verified.

North American market

Product / brandDescription & capabilitiesTarget customerLaunch / latestPricingStatus / notes
VIBE® — Original Gel Mattress (12-inch gel memory foam)Flagship all-foam gel-infused memory-foam mattress shipped compressed (mattress-in-a-box); named "Best Mattress Overall on Amazon" for three consecutive years by Forbes.comOnline consumers (Amazon), mass retail (Walmart from late 2025)Licensed Nov 2022; brand owned from Jul 2025Line designed to retail US$399–699 (queen) per Jan 2023 trade pressOwned (IP bought for US$4.6M, Jul 2025)
VIBE 12-inch Quilted Hybrid MattressFoam + innerspring hybridOnline / retailPre-2023 assortment, retainedWithin US$399–699 queen bandOwned
VIBE 8-inch and 10-inch foam; 10-inch and 12-inch hybrid modelsRange extensions announced 2023Value-to-mid consumersPlanned from Q2 2023—Owned
VIBE pillows, toppers, mattress pads, foundation framesTop-of-bed accessories (e.g., smart-edge pillow; 1.5-inch zoned, 3-inch gel swirl and 4-inch wave toppers announced Mar 2023)Online / retail2023 onwards—Owned
Mattress-in-a-Box (OEM/private label)Compressed, roll-packed foam and hybrid mattresses manufactured for retailers and brands; repeatedly cited by management as the key US growth product (FY2022–FY2025 prospects)US retailers, DTC brandsOngoing—OEM
EcossentialsIn-house sustainable sleep line using USDA BioPreferred-certified memory foam and FSC-certified recycled-content packagingRetail private label & own brandShowcased Mar 2023—Owned (per trade press)
Spa Supreme, ComforZen, Dream Serenity, Zeopedic, Zeosleep, Customizer, Kids Pedic, Cradlez, XCOR, Design, PureLUX, AwakenMemory-foam pillows, toppers and mattresses under various Sinomax-associated brand namesUS retail and online———
Sharper Image, Homedics (sleep products)Branded sleep/comfort products under well-known consumer brandsUS retail———
Dormeo OctaspringHybrid foam-spring ("Octaspring" foam springs) mattresses and toppers associated with Dormeo North America, in which Sinomax USA invested in Oct 2015US consumers———
Temperature-regulation and bio-based technologiesCarbon-based "adaptive" thermal technology (cools when hot, warms when cold); bio-based antimicrobial and cooling treatments; offered as turnkey solutions for private labelRetail private-label buyersIntroduced spring 2023—Proprietary (per company statements to trade press)

China market (PRC, Hong Kong, Macau)

Product / brandDescriptionTarget customerChannelPricing
SINOMAX visco-elastic pillowsMemory-foam contour and standard pillows; the brand's core retail productMiddle-class consumers in HK, Macau and PRCOwn stand-alone shops, department-store concession counters, online platforms—
SINOMAX mattresses and mattress toppersMemory-foam and hybrid mattresses, toppersSameSame—
SINOMAX health and household productsOther comfort products (cushions, lumbar supports etc. — exact range NPD)SameSame; also corporate sales—
Tung Ah (東亞) polyurethane foamBulk slabstock and specialty polyurethane foamPRC furniture and upholstery manufacturersB2B wholesaleNot disclosed; commodity-linked

Foam sales were HK$1,369.9M in FY2025 (29.2% of Group revenue) and HK$656.0M in 1H2026 (+15.7% YoY).

Europe and other overseas markets

Product / platformDescriptionNotes
M DK Holdings ApS product rangeR&D, design, sourcing, trading, quality assurance and control of sleep products, furniture and home accessories, focused on Denmark, the EU and the USConsolidated from 5 Aug 2025; contributed HK$603.8M revenue and a HK$11.6M net loss for 5 Aug–31 Dec 2025. The target group holds certain distribution rights granted by affiliates of a licensor, giving rise to a continuing connected transaction under Listing Rule 14A.60 (licensor identity NPD in sources reviewed)
Group-manufactured sleep products and foam for European and other customersPillows, toppers, mattresses and foam from China/VietnamCustomer names NPD

Services

The Group provides no material standalone services. Aggregator profiles mention "provision of treasury management services" as a subsidiary activity; this is intra-group and immaterial to revenue.

Financial Narrative

All figures HK$M, audited, from the FY2022, FY2024 and FY2025 annual results announcements unless noted. FY2022 figures are as originally reported (see §4.4 restatement note).

Income statement

Notes: FY2021 and FY2022 operating profit is derived as PBT plus finance costs (the Group did not present an "operating profit" subtotal in those years). EBITDA = operating profit + depreciation of PP&E, right-of-use assets and investment properties + amortisation; because IFRS 16 right-of-use depreciation is included, EBITDA is post-IFRS 16 and lease-inflated.

Margins and growth

Revenue CAGR: FY2021–FY2025 = 2.5% (distorted by the FY2021 peak and FY2022 collapse); FY2022–FY2025 = 14.2%.

Commentary — income statement. The five-year arc has four distinct phases. FY2021 was a volume peak (revenue +31.8%) on the back of pandemic-era home-goods demand, but the margin structure was poor: gross margin of 16.8% reflected surging chemical feedstock and container-freight costs that the Group could not pass through, leaving a net margin of 0.7%. FY2022 was the trough — revenue fell 26.0%, with China down 33.8% (lockdowns hit both retail and foam demand) and North America down 22.8% (US retailer overstock) — yet gross margin actually rose 3 points to 19.8% as raw-material and freight prices normalised; the loss came from operating deleverage. FY2023–FY2024 was the recovery: gross margin re-based to ~25.5% (lower raw materials, production efficiency), revenue grew at 13–15% a year, operating margin reached 6.0% and net profit doubled to HK$162.6M in FY2024 — the best result of the period.

FY2025: marks an inflection toward "growth with lower quality". Revenue grew 14.8% to a record, but gross margin fell 2.1 points to 23.5% as new 2024 factory leases in Vietnam and the US raised overheads, and US tariffs on exports plus FX losses (net exchange loss HK$22.1M) hit profit. Reported operating profit of HK$167.2M is flattered by an HK$85.0M non-cash remeasurement gain on the previously held 45% M DK stake and depressed by HK$45.1M of impairments on North American PP&E (HK$27.4M) and right-of-use assets (HK$17.7M). Stripping both, underlying operating profit was ~HK$127.3M (2.7% margin), down 48% from FY2024. Selling expenses grew faster than revenue (+19.3%), driven by marketing (+HK$57.9M) and transport (+HK$19.3M); admin rose 16.2% on headcount. Tax losses not recognised jumped to HK$45.5M of tax effect, signalling loss-making subsidiaries (most likely the US and the newly consolidated M DK).

1H2026 interim snapshot

The 1H2026 pattern intensifies FY2025's: gross margin recovered 3.0 points on mix (more higher-margin segments), but selling costs jumped 64.3% (channel fees +HK$63.0M, marketing +HK$44.9M, transport +HK$40.1M) and admin 55% (staff +HK$47.9M). Management notes Q2 expenses fell versus Q1, and blames March–April 2026 Middle East-related raw-material and logistics cost spikes it could not fully pass on (profit warning, 6 Aug 2026).

Balance sheet

Notes: No goodwill line was presented in FY2021/FY2022 balance sheets (shown as 0). The origin of the HK$5.3M goodwill first appearing in FY2023 is not explained in the documents reviewed. All bank borrowings are classified current/repayable on demand in every year. At 30 Jun 2026: cash HK$262.9M; bank borrowings HK$735.5M (trade financing 454.6; revolving 156.0; term 125.0); leases HK$266.8M; goodwill HK$177.5M; owners' equity HK$1,062.8M.

Commentary — balance sheet. Two features dominate. First, all bank debt is short-term (trade finance, revolvers and on-demand term loans), refinanced continuously against facilities of HK$1,658.1M (HK$795.2M utilised at 30 Jun 2026). This has worked through the cycle, but covenant breaches in 2020 and 2022 (the latter on HK$35.9M, waived) show the structure's fragility. Second, the balance sheet is being re-levered to fund growth: net bank debt (excluding leases) more than doubled from HK$138.7M (FY2024) to HK$327.8M (FY2025) and rose further to ~HK$472.6M at 30 Jun 2026, while the company's own debt-to-equity (net debt/equity) ratio went from 13.9% to 30.4% to 43.0%. The M DK step-acquisition added HK$168.8M of goodwill against net identifiable assets of only HK$31.8M — i.e., ~91% of the consideration is goodwill attached to a business that lost money after consolidation. Working capital also absorbed cash: receivables over 180 days rose from HK$38.5M (Dec 2025) to HK$69.2M (Jun 2026) and the credit-loss allowance from HK$25.0M to HK$35.9M.

Cash flow

Notes: Lease principal repayments (financing cash flows) were not available in the announcements reviewed, so "free cash flow" here is before lease payments; given right-of-use depreciation of HK$84–106M a year, lease-adjusted FCF would be materially lower. Dividends to owners derived: FY2024 = FY2023 final (HK1.3¢ × 1,750M = HK$22.75M) + FY2024 interim (HK$17.5M); FY2025 = FY2024 final (HK$22.75M) + FY2025 interim (HK$8.75M). No buybacks in FY2022–FY2025 (confirmed in each results announcement); FY2021 assumed nil (not separately verified). 1H2026 operating cash flow: HK$8.3M (1H2025: HK$33.8M); 1H2026 capex HK$36.9M.

Commentary — cash flow. FY2023's HK$420.3M operating cash flow was a working-capital release year (inventory down, payables up), not a structural level. Since then operating cash flow has fallen every period while capex has risen, and 1H2026 operating cash flow of just HK$8.3M against HK$36.9M capex means the Group funded growth, dividends and lease payments with borrowings. Dividend cuts (FY2025 total DPS down 57%; no 1H2026 interim) are consistent with conserving cash.

Ratios

ROIC uses the effective tax rate (bounded 0–50%). Year-end balances for DIO/DSO/DPO; FY2025 balances include M DK consolidated for only five months of income, which inflates DSO/DIO.

Ratio commentary. FY2024 was the high-water mark on every return metric (ROE 14.5%, ROIC 13.5%, coverage 4.9x). FY2025 roughly halved returns despite record revenue, and FY2025 interest coverage of 2.8x falls to ~2.1x on an underlying basis (excluding the remeasurement gain and impairments). The company-reported gearing ratio of 64.5% (FY2025) and 66.9% (Jun 2026) is the highest of the five-year window.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsProducts / services

China market

Manufacture and sale to customers in the PRC, Hong Kong and Macau

Health and household products (SINOMAX retail, concession counters, e-commerce, corporate sales) and polyurethane foam (Tung Ah) to furniture makers

North American market

Manufacture and sale to customers in the US, Canada and other North American countries

Health and household products (mattresses incl. mattress-in-a-box, toppers, pillows; OEM/private label; VIBE brand; e-commerce)

Europe and other overseas markets

All other customers

Health and household products and foam; since Aug 2025 includes consolidated M DK Holdings (Denmark/EU trading)

Segment revenue (HKD Mn)

Segment revenue (HKD Mn)FY2021FY2022FY2023FY2024FY2025

China market (HKD Mn)

2,222.91,470.71,589.61,748.81,857.7

North American market (HKD Mn)

1,573.41,214.21,384.71,624.61,773.6

Europe and other overseas markets (HKD Mn)

463.6467.0634.6717.71,065.4

Total (HKD Mn)

4,259.93,152.03,608.94,091.14,696.7

Segment YoY growth (%)

Segment YoY growth (%)FY2021FY2022FY2023FY2024FY2025

China market YoY (%)

0-33.88.110.06.2

North American market YoY (%)

0-22.814.017.39.2

Europe and other overseas YoY (%)

00.735.913.148.4

Total YoY (%)

0-26.014.513.414.8

Segment share of revenue (%)

Segment share of revenue (%)FY2021FY2022FY2023FY2024FY2025

China market (%)

52.246.744.042.739.6

North American market (%)

36.938.538.439.737.8

Europe and other overseas (%)

10.914.817.617.522.7

Revenue by Segment

Segment (HKD Mn)1H20251H2026Change (%)

China market

792.5962.821.5

North American market

692.01,138.964.6

Europe and other overseas

407.6474.616.5

Total

1,892.12,576.336.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Group Entities

EntityJurisdictionRole

Sinomax Group Limited

Cayman Islands

Listed holding company

Sinomax Enterprises Limited

BVI

Controlling shareholder (parent)

Treasure Range Holdings Limited

—

Wholly owned; holds the 55% stake in M DK Holdings ApS

M DK Holdings ApS ("MDKH") and subsidiaries

Denmark (operations in Denmark, EU and US)

55% subsidiary since 4 Aug 2025; 45% held by M Logistical

Sinomax USA, Inc.

United States (Houston, TX HQ)

US manufacturing, sales; owner of VIBE IP

Sinomax (Vietnam) Polyurethane Technology ("Sinomax Vietnam")

Vietnam

Manufacture and sale of polyurethane foam

Sinomax Vietnam Household Products ("Sinomax Vietnam HP")

Vietnam

Manufacture and sale of health and household products

Sinomax (Zhejiang) Polyurethane Technology Limited

PRC

Foam; former owner of Chengdu Xingang stake

Sinomax (Zhejiang) Polyurethane Household Products Ltd.

PRC

Household products

Sinomax Kuka Zhejiang Foam Co.

PRC (Haining)

Foam; lessee under Haining lease

Sinomax Health & Household Products Ltd.

—

Health & household products

Sinomax Macao Commercial Offshore Ltd.

Macau

Trading

Sinomax International Trading Ltd. / Sinomax International Investment Ltd.

—

Trading / holding

“—” = not publicly disclosed.

Income statement (HKD Mn)

Income statement (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

4,259.93,152.03,608.94,091.14,696.7

Cost of sales (HKD Mn)

3,542.92,529.22,689.23,044.23,594.4

Gross profit (HKD Mn)

717.0622.7919.71,047.01,102.3

Selling and distribution expenses (HKD Mn)

420.2424.5458.4494.3589.7

Administrative expenses (HKD Mn)

199.2188.7250.2267.4310.8

Research and development costs (HKD Mn)

67.474.480.288.089.7

Other income (HKD Mn)

63.154.127.954.945.7

Other gains/(losses), net (HKD Mn)

-11.725.514.9-11.916.0

Operating profit (HKD Mn)

76.8-3.2172.4244.6167.2

Depreciation and amortisation incl. right-of-use (HKD Mn)

160.2168.5150.2159.7192.9

EBITDA, derived (HKD Mn)

237.0165.3322.6404.2360.0

Finance costs (HKD Mn)

38.946.049.850.159.1

Share of associate (HKD Mn)

0005.0-0.2

Profit/(loss) before tax (HKD Mn)

37.9-49.2122.6199.5107.9

Income tax expense/(credit) (HKD Mn)

6.4-12.042.136.823.0

Profit/(loss) for the year (HKD Mn)

31.4-37.280.5162.684.8

Attributable to owners (HKD Mn)

15.3-36.062.6138.160.3

Attributable to non-controlling interests (HKD Mn)

16.1-1.217.924.624.5

Basic EPS (HK cents)

0.87-2.063.587.893.45

Diluted EPS (HK cents)

0.87-2.063.587.893.45

Final DPS (HK cents)

0.401.31.30.5

Margins and growth (%)

Margins and growth (%)FY2021FY2022FY2023FY2024FY2025

Revenue growth YoY (%)

31.8-26.014.513.414.8

Gross margin (%)

16.819.825.525.623.5

Operating margin (%)

1.8-0.14.86.03.6

EBITDA margin (%)

5.65.28.99.97.7

Net margin (%)

0.7-1.22.24.01.8

R&D as % of revenue (%)

1.62.42.22.21.9

S&D as % of revenue (%)

9.913.512.712.112.6

Admin as % of revenue (%)

4.76.06.96.56.6

1H income statement (HKD Mn)

1H income statement (HKD Mn)1H20251H2026

Revenue

1,892.12,576.3

Gross profit

442.4680.7

Gross margin (%)

23.426.4

Selling and distribution

235.1386.2

Administrative

119.2184.9

R&D

39.247.5

Operating profit

53.351.6

Finance costs

24.729.1

Profit for the period

30.420.0

Attributable to owners

26.911.8

Basic EPS (HK cents)

1.540.67

Balance Sheet

Balance sheet (HKD Mn, at 31 Dec)FY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

2,828.92,237.92,406.12,557.03,244.0

Cash and cash equivalents (HKD Mn)

228.5169.0309.9262.4367.8

Unsecured bank borrowings — current (HKD Mn)

588.3522.3441.9401.1695.6

Bank borrowings — non-current (HKD Mn)

00000

Lease liabilities — current (HKD Mn)

84.163.572.691.9124.0

Lease liabilities — non-current (HKD Mn)

272.5236.2208.1250.8240.4

Total debt incl. leases (HKD Mn)

944.9822.0722.6743.81,060.1

Net debt incl. leases (HKD Mn)

716.3653.0412.7481.4692.3

Net bank debt excl. leases (HKD Mn)

359.7353.3132.0138.7327.8

Total equity (HKD Mn)

1,006.6886.9918.5999.81,079.2

Equity attributable to owners (HKD Mn)

992.8895.2925.8973.71,032.0

Non-controlling interests (HKD Mn)

13.8-8.3-7.326.147.3

Goodwill (HKD Mn)

005.35.2177.3

Intangible assets (HKD Mn)

13.011.29.47.649.8

Inventories (HKD Mn)

703.3555.3508.7476.5660.1

Trade receivables, net (HKD Mn)

658.7435.7542.9626.0837.3

Trade payables (HKD Mn)

598.7310.2452.7487.0705.1

Net current assets / working capital (HKD Mn)

377.7277.0339.4370.2290.6

Cash flow (HKD Mn)

Cash flow (HKD Mn)FY2021FY2022FY2023FY2024FY2025

Net cash from operating activities (HKD Mn)

156.8191.0420.3249.9207.0

Capital expenditure (HKD Mn)

48.651.062.265.892.8

Free cash flow before lease payments, derived (HKD Mn)

108.2140.0358.1184.1114.2

Dividends paid to owners, derived (HKD Mn)

NPD

NPD

NPD

40.331.5

Dividends paid to NCI (HKD Mn)

4.914.015.22.721.8

Share buybacks (HKD Mn)

00000

Margin Analysis (%) and Financial Ratios (x)

RatiosFY2021FY2022FY2023FY2024FY2025

ROE on average owners' equity (%)

1.5-3.86.914.56.0

ROA on average total assets (%)

1.1-1.53.56.62.9

ROIC, after-tax operating profit / (equity + net debt) (%)

3.7-0.28.513.57.4

Current ratio (x)

1.251.251.271.291.15

Quick ratio, company-reported (%)

78.774.686.691.880.7

Gearing ratio, company-reported interest-bearing debt / equity (%)

58.458.948.140.164.5

Debt-to-equity, company-reported net debt / equity (%)

35.739.814.413.930.4

Total debt incl. leases / equity (x)

0.940.930.790.740.98

Net debt incl. leases / EBITDA (x)

3.023.951.281.191.92

Interest coverage, operating profit / finance costs (x)

1.97-0.073.464.882.83

Asset turnover (x)

1.511.241.551.651.62

Days inventory outstanding (days)

72.580.169.157.167.0

Days sales outstanding (days)

56.450.554.955.965.1

Days payables outstanding (days)

61.744.861.558.471.6

Cash conversion cycle (days)

67.285.862.554.660.5

Revenue by country/region (HKD Mn)

Revenue by country/region (HKD Mn)FY2021FY2022FY2023FY2024FY2025

PRC (HKD Mn)

1,913.11,222.11,295.21,481.61,521.6

Hong Kong, Macau and others (HKD Mn)

309.8248.6294.5267.2336.1

United States (HKD Mn)

1,443.01,128.81,280.81,379.41,550.7

Other North America (HKD Mn)

130.585.4103.9245.2222.9

Europe and other overseas (HKD Mn)

463.6467.0634.6717.71,065.4

Total (HKD Mn)

4,259.93,152.03,608.94,091.14,696.7

Country/region YoY growth (%)

Country/region YoY growth (%)FY2023FY2024FY2025

PRC (%)

6.014.42.7

Hong Kong, Macau and others (%)

18.4-9.325.8

United States (%)

13.57.712.4

Other North America (%)

21.6136.1-9.1

Europe and other overseas (%)

35.913.148.4

1H revenue by country (HKD Mn)

1H revenue by country (HKD Mn)1H20251H2026Change (%)

PRC

665.9800.820.3

Hong Kong, Macau and others

126.6162.027.9

United States

578.41,024.077.0

Other North America

113.6114.91.1

Europe and other overseas

407.6474.616.5

Non-current assets by location (HKD Mn)

Non-current assets by location (HKD Mn)FY2021FY2022FY2023FY2024FY2025

United States (HKD Mn)

493.3461.9405.7386.7438.0

PRC (HKD Mn)

324.6268.7283.9253.6247.8

Hong Kong (HKD Mn)

12.316.924.724.623.9

Vietnam (HKD Mn)

45.627.727.591.086.7

Europe (HKD Mn)

00054.7162.7

Year-end share price (HKD)

Year-end share price (HKD)FY2021FY2022FY2023FY2024

Closing price at 31 Dec (HKD)

0.2350.0690.0700.250

Performance Details

Performance (approximate, to 17 Sep 2026)Value

~1-year (vs ~HK$0.22, Sep–Oct 2025)

≈ −45%

~3-year (vs HK$0.070 at end-2023)

≈ +71%

~5-year (vs HK$0.235 at end-2021)

≈ −49%

Annualised return since 2014 listing (Lixinger, mid-2026)

−12.06%

Valuation Snapshot

MetricValueBasis

Market capitalisation

HK$210.0M

1,750.0M shares × HK$0.12

Enterprise value

≈HK$987M

Market cap + bank borrowings 735.5 + lease liabilities 266.8 − cash 262.9 + NCI 37.4 (30 Jun 2026)

P/E (TTM attributable earnings HK$45.2M)

≈4.6x

H2 2025 HK$33.4M + 1H2026 HK$11.8M; Lixinger 4.65x

P/B

≈0.20x

Owners' equity HK$1,062.8M (Jun 2026); 10jqka 0.21x

EV/Sales (TTM revenue HK$5,380.9M)

≈0.18x

H2 2025 HK$2,804.6M + 1H2026 HK$2,576.3M

EV/EBITDA (TTM EBITDA ≈HK$372.6M, post-IFRS 16)

≈2.6x

H2 2025 HK$216.0M + 1H2026 HK$156.6M; includes FY2025 one-offs

Dividend per share (HK cents)

Dividend per share (HK cents)FY2021FY2022FY2023FY2024FY2025

Final DPS (HK cents)

0.401.31.30.5

Capital Instruments

InstrumentAmount (HKD Mn)MaturityPricing

Trade financing

454.6

Within 1 year

HIBOR / SOFR / LPR + margin

Revolving borrowings

156.0

Within 1 year / on demand

Variable

Term borrowings

125.0

Within 1 year / on demand

Variable or fixed (some PRC loans 2.00–2.42%)

Total bank borrowings

735.5

All current

Effective rates 2.00–6.69%

Lease liabilities — current

97.9

Within 1 year

—

Lease liabilities — non-current

168.8

Beyond 1 year

—

Banking facilities available

1,658.1—

HK$795.2M utilised (incl. bill payables); no assets pledged

Analyst Conclusions

Management guidance

Qualitative only. For 2H2026, management intends to leverage the enlarged MDKH platform to deepen US and European penetration, strengthen sales and marketing, broaden the customer base, streamline operations and improve cost efficiency, while monitoring trade policy and raw-material costs; the Board remains "cautiously optimistic". No numerical revenue, margin or earnings guidance has been given.

Consensus expectations

No sell-side consensus is publicly available (see §21.3). Mechanically, a full year of M DK consolidation (versus five months in FY2025) and 1H2026's +36% growth point to FY2026 revenue well above FY2025's HK$4.7bn, but earnings direction depends on 2H cost discipline.

Bull case

  1. Scale is arriving faster than expected: 1H2026 revenue +36.2% and gross profit +53.9%; full-year MDKH consolidation and VIBE retail rollout could take FY2026 revenue towards a new record with a structurally higher gross margin (26.4% in 1H2026 vs 23.5% FY2025).

  2. Cost normalisation creates operating leverage: selling expenses at 15.0% of 1H2026 revenue versus 12.1% in FY2024; reversion toward ~12–13% on a >HK$5bn revenue base would add tens of millions in operating profit, and management notes Q2 costs already fell versus Q1.

  3. Extreme valuation cushion: at ~0.2x book, ~4.6x trailing P/E and ~2.6x EV/EBITDA, the market prices in permanent impairment; any stabilisation of earnings could re-rate the shares meaningfully, and dividends have been maintained at a ~30% payout through FY2025.

Bear case

  1. Growth is being bought, not earned: attributable profit fell 56% in both FY2025 and 1H2026 despite rising sales; underlying FY2025 operating margin was ~2.7%, and three consecutive profit warnings (Aug 2025, Feb 2026, Aug 2026) show poor earnings visibility.

  2. Balance-sheet and cash-flow strain: gearing 66.9%, all bank debt short-term, 1H2026 operating cash flow of only HK$8.3M, and the interim dividend suspended — a further profit shock could revive the covenant issues of 2020/2022.

  3. Asset-quality risks: HK$177.5M of goodwill (mostly MDKH, loss-making post-acquisition), HK$45.1M of US impairments already booked, and rising long-dated receivables (HK$69.2M aged 181–365 days) point to possible further write-downs.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
OngoingUS tariff policy changes affecting China/Vietnam-made bedding; anti-dumping reviews
OngoingPolyol/isocyanate prices and freight after the Mar–Apr 2026 Middle East disruption
Feb 2027 (expected)Possible FY2026 profit alert (pattern of February/August warnings)
Mar 2027 (expected)FY2026 annual results — full-year MDKH contribution, goodwill impairment test, US asset utilisation, final dividend decision
2026–2027Renewal of PRC HNTE 15% tax status (expires 2026)
2026–2027Renewal of 2024–2026 Haining lease; 2027 Dongguan lease (connected transactions)
OngoingVIBE retail distribution beyond Amazon/Walmart
OngoingReceivable ageing, credit-loss allowances, operating cash flow and gearing trajectory
2,027HKFRS 18 adoption with restated 2026 comparatives

Concluding analyst verdict

Sinomax has executed a credible strategic pivot since the FY2022 trough: it rebuilt gross margins to the mid-20s, diversified away from a China-centric foam business, built a three-country production network suited to an era of tariffs and anti-dumping duties, bought an Amazon-proven mattress brand cheaply, and acquired control of a European distribution platform. Revenue is at record levels and accelerating, with 1H2026 up 36% and the United States up 77%.

The problem is that almost none of this growth has reached shareholders. Attributable profit has fallen by more than half in each of the last three reported periods, and FY2025's headline profit was flattered by an HK$85M non-cash remeasurement gain. Selling, channel and staff costs are rising faster than gross profit; operating cash flow has collapsed to near zero in 1H2026; gearing is at a five-year high with every dollar of bank debt short-term; and the balance sheet now carries HK$177M of goodwill tied to a loss-making acquisition. The Group's history of covenant breaches in 2020 and 2022 means these trends deserve close attention.

The market has priced this scepticism aggressively: a ~HK$210M market capitalisation, ~0.2x book and ~4.6x trailing earnings imply that investors either expect write-downs or discount the controlling shareholder's ~73% stake and related-party lease arrangements. For a value investor the asymmetry is real — modest cost normalisation on a HK$5bn+ revenue base would transform earnings — but it is contingent on management demonstrating in 2H2026 that the commercial build-out is ending and that MDKH can break even.

Verdict: a deep-value, high-execution-risk special situation rather than a quality compounder. Evidence to watch before taking a constructive view: FY2026 operating cash flow turning positive, selling-expense ratio falling back toward 12–13%, no goodwill impairment on MDKH, and gearing stabilising. Absent those, the low multiple is more likely a value trap than an opportunity.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleDirector since (per aggregator)Year of birth / ageBackground (verified items only)

Mr. LAM Chi Fan ("Frankie Lam")

Non-executive Director, Chairman of the Board; Chairman of the Nomination Committee

2012

Born 1959

Founder-era Chairman; re-designated from executive to non-executive Director (date per 2024 Annual Report, between Mar 2023 and Feb 2025)

Mr. CHEUNG Tung

Executive Director, President

2012 (President since 2003 per Zonebourse)

Born 1976

Director of multiple PRC and offshore subsidiaries (Sinomax Kuka Zhejiang Foam, Sinomax (Zhejiang) Polyurethane Household Products, Sinomax Macao Commercial Offshore etc.); former director of Sinomax USA

Mr. CHEN Feng

Executive Director

2012

Born 1964

Detailed bio NPD in sources reviewed

Mr. LAM Kam Cheung ("Kelvin Lam")

Executive Director, Chief Financial Officer and Company Secretary; authorised representative

2012

Born 1968

Joined Dormeo NA board in 2015 on Sinomax's investment

Ms. LAM Fei Man

Executive Director

2012

Born 1975

—

Mr. WONG Chi Keung

Independent Non-executive Director; Chairman of the Audit Committee and of a second board committee

2014

Age 54 (Investing.com)

INED since listing

Mr. ZHANG Hwo Jie

Independent Non-executive Director

2014

Age 60 (Investing.com)

—

Dr. CHEUNG Wah Keung

Independent Non-executive Director

2023

Age 62 (Investing.com)

Appointed in the June 2023 board refresh

Directors' Remuneration

DirectorTotal pay (HKD Mn, FY2023 per aggregator)Salary / bonus / equity split

Chen Feng

2.29

NPD

Cheung Tung

2.11

NPD

Lam Chi Fan

2.04

NPD

Lam Kam Cheung

1.92

NPD

Lam Fei Man

1.25

NPD

Board & Management Changes

DateChange

12 Jun 2023

INED resignation (Prof. Lam Sing Kwong Simon per committee-history inference; name not explicitly confirmed in retrieved text) and committee changes

16 Jun 2023

Committee re-composition

28 Jun 2023

Further director appointments/re-designations; Dr Cheung Wah Keung joins as INED

Mar 2023–Feb 2025

Lam Chi Fan re-designated from executive Director to non-executive Director (Chairman)

16 May 2025

Change affecting Ms Lam Fei Man (per 2025 Interim Report)

Major Shareholders

HolderShares%As at

Sinomax Enterprises Limited (BVI, controlling shareholder)

1,275,906,00072.91

Nov 2019 (latest verified)

Public float (implied)

~474,096,000

~27.09

Nov 2019

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning

North America — branded & OEM bedding

Somnigroup International (formerly Tempur Sealy; NYSE: SGI)

Global leader; owns Tempur-Pedic memory foam brand

Category creator in visco-elastic; vastly larger scale and brand power; competitor and potential customer

North America

Serta Simmons Bedding (private)

Major US mattress maker

Historically a Sinomax customer; also a competitor in branded mattresses

North America

Sleep Number (NASDAQ: SNBR)

Vertically integrated smart-bed retailer

Different model (own stores); competes for premium sleep spend

North America — bed-in-a-box

Zinus (Hyundai Livart group, Korea)

Large-scale Asian-manufactured mattress-in-a-box

Direct rival on Amazon/Walmart value mattresses — closest analogue to VIBE

North America — bed-in-a-box

Casper, Nectar/Resident (private)

DTC brands

Compete for online share; also outsource manufacturing

North America — foam OEM

Healthcare Co. Ltd. / MLILY (Shanghai-listed)

Chinese memory-foam OEM/ODM with US factories

Most direct global peer: same product set, same customer types, same tariff exposure

North America — foam

Keeson Technology (Shanghai-listed)

Smart beds/adjustable bases, mattress OEM

Adjacent OEM competitor

China — branded retail

De Rucci (Shenzhen-listed), Xilinmen (Shanghai-listed)

Chinese mattress brands

Much larger domestic brands; compete for SINOMAX retail customers

China — foam

Regional PU foam converters (fragmented; names NPD)

Commodity foam

Price-based competition for furniture-maker volume

Hong Kong home furnishings

International Housewares Retail (1373.HK), Royale Home (1198.HK), Hing Lee (HK) (0396.HK), Morris Home (1575.HK), Huisen Household (2127.HK)

HK-listed home goods/furniture peers

Comparable small-cap valuation universe

Europe

Emma (Germany), Dormeo/Studio Moderna, regional sourcing houses

Bed-in-a-box and trading

Compete with the M DK platform

Peer Comparison FY2025

CompanyTickerPrice (HKD)Market cap (HKD Mn)P/E (x)1-year price change (%)

Sinomax Group

1418.HK

0.23390.253.796.67

International Housewares Retail

1373.HK

0.77557.1411.76-22.00

Royale Home Holdings

1198.HK

0.15384.59

NPD (loss)

-45.19

Hing Lee (HK) Holdings

0396.HK

0.1296.165.6925.88

Morris Home Holdings

1575.HK

0.05183.78

NPD

-28.57

Huisen Household International

2127.HK

0.0276.58

NPD

-56.52

Sinomax internal benchmark

FY2023

FY2024

FY2025

——

Revenue growth (%)

14.513.414.8——

Gross margin (%)

25.525.623.5——

Operating margin (%)

4.86.03.6——

R&D intensity (%)

2.22.21.9——

Company Snapshot

$602.9M

Revenue

4,028

Employees

2000

Founded

Kowloon, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Record scale and momentum: FY2025 revenue HK$4,696.7M (+14.8%) and 1H2026 revenue +36.2% to HK$2,576.3M — the highest run-rate in company history.
  • Tri-continental manufacturing: non-current assets of HK$438.0M in the US, HK$247.8M in the PRC and HK$86.7M in Vietnam (FY2025) provide tariff-route flexibility few Chinese peers can match.
  • Gross-margin resilience in 1H2026: 26.4%, up 3.0 points YoY on mix, the best half-year margin in the period reviewed.
  • Owned digital brand: VIBE — Forbes.com "Best Mattress Overall on Amazon" three years running; bought for only US$4.6M versus a US$800k/yr minimum royalty.
  • Diversified revenue base: China 39.6%, North America 37.8%, Europe & other 22.7% (FY2025); Europe & other up from 10.9% in FY2021.
  • Stable, experienced management with the same Chairman, President and CFO since listing (2014) and an auditor of international standing (PwC).

Weaknesses

  • Thin profitability: FY2025 net margin 1.8%; underlying operating margin ~2.7% excluding the HK$85.0M remeasurement gain and HK$45.1M impairments.
  • Rising operating costs outpacing gross profit: 1H2026 selling expenses +64.3% and admin +55% versus gross profit +53.9%; attributable profit −56.1%.
  • All bank debt short-term: HK$735.5M of borrowings repayable within one year or on demand (Jun 2026); covenant breaches in 2020 and 2022.
  • Deteriorating cash generation: 1H2026 operating cash flow HK$8.3M against HK$36.9M capex.
  • Underperforming US assets: HK$45.1M North American impairments in FY2025 and gross-margin dilution from 2024 US/Vietnam leases.
  • Related-party operating dependence: core Dongguan factory (since 2007) and Haining site (since 2006) leased from entities controlled by the controlling shareholder.

Opportunities

  • M DK full-year consolidation: pro-forma figures disclose ~HK$1,544.9M of annual revenue for the acquired business, versus HK$603.8M consolidated in FY2025 — a large FY2026 revenue uplift.
  • VIBE omnichannel expansion from Amazon into Walmart and other retailers, and outside the formerly licensed territories.
  • Near-shoring demand: US retailers seeking non-China supply can use La Vergne and Vietnam capacity.
  • China foam share gains: PRC revenue +20.3% in 1H2026 on higher foam market share.
  • Operating leverage once the commercial build-out matures: Q2 2026 expenses already below Q1; normalising selling costs back to FY2024's 12.1% of revenue would materially lift margins.
  • Deep-value re-rating potential: P/B ≈0.2x and P/E ≈4.6x (Sep 2026) leave room for multiple expansion if earnings stabilise.

Threats

  • Tariff escalation and anti-dumping: US tariffs explicitly drove the FY2025 profit decline; AD orders cover China (2019) and Vietnam (2021) mattresses.
  • Raw-material and logistics shocks: Mar–Apr 2026 Middle East disruption costs not fully passed on.
  • Goodwill impairment risk: HK$177.5M goodwill (Jun 2026), mostly on MDKH, which made a HK$11.6M loss post-acquisition.
  • Customer credit risk: receivables aged 181–365 days rose to HK$69.2M (Jun 2026) from HK$38.5M (Dec 2025); credit-loss allowance up to HK$35.9M; SSB's 2023 Chapter 11 shows customer fragility.
  • Expiry of PRC HNTE 15% tax rate in 2026 — renewal not guaranteed.
  • Refinancing/covenant risk if profits fall further, given all-current borrowing and gearing at 66.9%.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
10 Apr 20252024 Annual Report publishedRecords FY2024 as the best year of the cycle (profit HK$162.6M)
16 May 2025AGM; FY2024 final dividend HK1.3¢ approvedDividend continuity
16 May 2025Board/committee change involving Ms Lam Fei Man effectiveGovernance housekeeping
4 Jul 2025FY2024 final dividend paid (≈HK$22.75M)Cash return
7 Jul 2025Sinomax USA agrees to buy VIBE IP for US$4.6MLicensee-to-owner; removes US$800k/yr minimum royalty
4 Aug 20251H2025 profit warning: profit ≥HK$30M vs HK$74.2M; tariffs citedFirst signal of tariff damage
4 Aug 2025Further EUR5.0M subscription; MDKH becomes 55% subsidiaryTransformational for Europe segment; HK$168.8M goodwill
19 Aug 20251H2025 results: revenue −5.5% to HK$1,892.1M; attributable profit −56.7% to HK$26.9M; GP −12.8% on new Vietnam/US lease overheadsMargin pressure from 2024 capacity additions
1 Sep 20252025 Interim Report published—
8 Oct 2025Interim dividend HK0.5¢ paid (≈HK$8.75M)Halved vs 1H2024 (HK1.0¢)
Oct–Nov 2025Shares trade HK$0.22–0.25; market cap ≈HK$390–430MPre-profit-warning range
1–2 Dec 2025Public announcement of VIBE acquisition; VIBE launches in Walmart storesBrand-building milestone
19 Dec 20252026 Dongguan Lease (connected transaction with Dongguan Donglian)Continues related-party dependency
13 Feb 2026FY2025 profit warning: profit after tax ≥HK$80M (FY2024: HK$162.6M); attributable ≥HK$55M; tariffs and FX citedGuidance revision
Feb 2026Shares fall ~28% (Simply Wall St); HK$0.20 by 16 FebMarket reaction
2 Mar 2026Board meeting notice—
Mar–Apr 2026Middle East geopolitical disruption raises raw-material and logistics costsLater cited in 1H2026 profit warning
24 Mar 2026FY2025 results: revenue HK$4,696.7M (+14.8%); profit HK$84.8M (−47.8%); attributable HK$60.3M; final DPS HK0.5¢; HK$45.1M US asset impairments; HK$85.0M remeasurement gainRecord sales, sharply lower earnings quality
1 Apr 2026Monthly return: no share changes; 1,750,002,000 sharesCapital structure stable
29 Apr 20262025 Annual Report and ESG report; AGM notice; circular on director re-election and general buyback mandateESG targets for 2030 published
29 May 2026AGM; FY2025 final dividend approved—
30 Jun 2026Headcount reaches 4,028 (+7.6% YoY)Cost base expansion
10 Jul 2026FY2025 final dividend paid (≈HK$8.75M)—
6 Aug 20261H2026 profit warning: profit ≈HK$20.0M vs HK$30.4M; US/Europe investment and raw-material costs cited; Q2 expenses below Q1Third consecutive profit warning
25 Aug 20261H2026 results: revenue +36.2% to HK$2,576.3M; GP +53.9%; attributable profit −56.1% to HK$11.8M; no interim dividend; gearing 66.9%Top-line momentum, bottom-line erosion
4 Sep 20262026 Interim Report published; P/E (TTM) ≈5.0x, P/B ≈0.21x (10jqka)Deep-value pricing
17 Sep 2026Shares at HK$0.12 (market cap ≈HK$210M)Near multi-year lows

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

7 charts
Income Statement: Revenue & Gross Profit (FY2021–FY2025): Revenue rose from HKD 4,259.9 Mn in FY2021 to HKD 4,696.7 Mn in FY2025.
Sinomax Group Limited — Income Statement: Revenue & Gross Profit (FY2021–FY2025)
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue4,259.93,1523,608.94,091.14,696.7
Cost of sales3,542.92,529.22,689.23,044.23,594.4
Gross profit717622.7919.71,0471,102.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1Sinomax Group — Announcement of Annual Results FY2025 (HKEXnews 2026032401338) — 24 Mar 2026 — FY2025/FY2024 financials, segments, M DK business combination, prospects, headcount, dividends
  2. S2Sinomax Group — Unaudited Interim Results 1H2026 (HKEXnews 2026082501103) — 25 Aug 2026 — 1H2026 financials, borrowings, facilities, prospects, headcount
  3. S3Sinomax Group — Announcement of Annual Results FY2024 (HKEXnews 2025031801873) — 18 Mar 2025 — FY2024/FY2023 financials, M DK associate, Chengdu receivable, prospects
  4. S4Sinomax Group — Announcement of Annual Results FY2022 (HKEXnews 2023032801765) — 28 Mar 2023 — FY2022/FY2021 financials, going concern, covenant breach, major customer, SSB Chapter 11
  5. S5FY2023 annual results (HKEXnews 2024032200949) and 2023 Annual Report (2024042200297) — Mar–Apr 2024 — FY2022 restated revenue, board changes, FY2023 ESG summary
  6. S62022 Annual Report (HKEXnews 2023042700895); 2024 Annual Report (2025041000345) — Apr 2023; Apr 2025 — Year-end share prices, awards, committees
  7. S7Profit warnings (HKEXnews 2025080402070; 2026021300707; 2026080600464) — 4 Aug 2025; 13 Feb 2026; 6 Aug 2026 — Guidance revisions, tariff and raw-material commentary
  8. S8Discloseable / connected transaction announcements: Vietnam leases (Mar–Jun 2024), Haining lease (28 Nov 2023), Dongguan leases (Oct 2024, 10 Dec 2024, 19 Dec 2025), M DK further subscription (5 Aug 2025), VIBE IP (7 Jul 2025, via Gelonghui), Chengdu disposal waiver (21 Nov 2019) — 2019–2025 — Deals, footprint, related-party arrangements
  9. S9Trade press: Furniture Today and Home Textiles Today (Jan & Mar 2023; Dec 2025); BedTimes and PUdaily (Dec 2025); WPLN and Business Facilities (2015–2016); ACN Newswire (Oct 2015) — Various — VIBE, product technologies, La Vergne plant, Dormeo NA
  10. S10Market data: TipRanks, Simply Wall St, Lixinger, 10jqka, Investing.com, Yahoo Finance, STCN, iTiger — 2025–2026 — Share price, market cap, peers, director ages/pay, ownership, 1H2026 report summary

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.